The pharmaceutical trade between India and Bermuda has been modest but consistent over the past few years. Between 2022 and 2026, India exported a total of $32,000 worth of pharmaceutical products to Bermuda, distributed across 25 shipments from eight Indian exporters to four Bermuda buyers. The average shipment value stood at approximately $1,280, indicating a steady, albeit small-scale, trade relationship.
The product mix has been diverse, with the top ten products accounting for 75% of the total export value. Notably, antiretroviral drugs such as Darunavir and Ritonavir tablets, as well as combination therapies like Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate tablets, have been prominent. Vaccines, particularly typhoid conjugate vaccines, also feature prominently in the export list. This suggests that India's pharmaceutical exports to Bermuda are primarily focused on essential medicines and vaccines, aligning with global health priorities.
The primary recipients of these exports include the Bermuda Hospital Board, which has received the majority of shipments, followed by the Department of Health and other entities. The export ports in India are predominantly Hyderabad Air Cargo and Sahar Air Cargo, indicating a reliance on air freight for these shipments. In Bermuda, the main import ports are the main island and St. George, UT, reflecting the centralized nature of pharmaceutical imports.
